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Serologic Evidence
of Hantavirus
Infection in
Humans, Colombia 
To the Editor: Several New World
hantaviruses cause hantavirus pul-
monary syndrome (HPS) in the
Americas. All hantaviruses that cause
HPS are hosted by the rodent family
Muridae, subfamily Sigmodontinae
(New World rats and mice). Since the
Sin Nombre virus (SNV) was docu-
mented in 1993 (1), ≈25 sigmodontine
hantavirus genotypes from the
Americas have been described; each
is associated with a different rodent
species or subspecies. Hantaviruses
have been documented in South
America from Argentina, Chile,
Paraguay, Uruguay, Bolivia, Brazil,
Peru, and Venezuela (2), and in
Central America from Costa Rica and
Panama (3,4). 
Although documented in four bor-
dering countries, hantaviruses have
not been documented in Colombia.
We assessed hantavirus antibody
prevalence in humans by screening
blood samples from rural volunteers
within Córdoba and Sucre provinces
in Colombia. Workers 16–65 years-
of-age from 12 communities were
enrolled. The research committee of
the University of Córdoba approved
the protocol, and informed consent
was obtained from all participants.
Participants were of low socioeco-
nomic status and lived in homes with
no running water and frequently no
electricity. These workers had lived in
the same general area all of their lives;
none had traveled outside of
Colombia. From January to October
2003, 88 blood samples were collect-
ed in 12 localities. Samples were
screened for immunoglobulin (Ig) G
antibody reactive with SNV antigen
by using enzyme immunoassay (5).
This assay detects, but does not distin-
guish among, all known sigmodontine
hantaviruses. SNV antibody was
detected in 12 samples (13.5%) repre-
senting 10 of 12 sites. Site-specific
prevalences (Figure) ranged from 5%
(1 of 19) to 50% (1 of 2). Except for
one category with no positive sam-
ples, prevalence of anti-SNV IgG was
similar across occupations (chi square
= 0.03, df = 3, p = 0.998). All 12 anti-
body-positive samples were from
male workers. We divided the study
population into five age categories
(18–24 years, n = 19; 25–34 years, n =
24; 35–44 years, n = 20; 45–54 years,
n = 15; 55–70 years, n = 10) and
found significant differences among
the proportions of antibody-positive
persons (chi square = 9.8, df = 4, p =
0.04). The higher prevalences were in
the two youngest age groups
(16%–17%) and the oldest age group
(40%); one antibody-positive sample
was found in the 35- to 54-year-old
group (3%). 
The prevalence of SNV-reactive
antibody in rural workers indicates
that at least one hantavirus is endemic
in rodents in northern Colombia and
is frequently transmitted to rural resi-
dents. This finding further supports
mounting evidence that hantaviruses
and HPS are a Pan-American problem
(2,6). The bimodal infection distribu-
tion among age groups suggests
human exposure might be episodic
with an extended periodicity.
Preliminary and limited rodent sam-
pling has not produced any hantavirus
antibody–positive samples. Although
their distributions are poorly studied,
both  Zygodontomys brevicauda
(reservoir of Calabazo virus in
Panama) and Oligoryzomys ful-
vescens (reservoir of Choclo virus, a
known agent of HPS in Panama [4])
are believed to be found in northern
Colombia (7).  
Despite the prevalence of antibod-
ies to a hantavirus in humans in north-
ern Colombia, we did not find any
human illnesses. None of the SNV
antibody–positive volunteers reported
illness compatible with HPS; howev-
er, some hantaviruses may cause mild
or no illness. Surveys have shown
hantavirus antibodies (13%–40%
prevalence in Paraguay and northern
Argentina [8], Bolivia [J.
Montgomery et al., unpub. data],
northern Brazil [P.F.C. Vasconcelos et
al., unpub. data], and Panama [6]) in
some populations with little evidence
of illness. 
Figure. Locations of 12 towns in Córdoba and Sucre departments, Colombia, where rural
workers were screened for antibody to Sin Nombre hantavirus. Numbers in parentheses
represent number of antibody-positive persons and number of persons tested.LETTERS
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Infection in rural workers and the
likely presence of O. fulvescens in
northern Colombia underscore the
importance of physician awareness
and surveillance for HPS. Asystemat-
ic survey of sigmodontine rodent pop-
ulations that will identify the han-
taviruses and their hosts is imperative.
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